(Q44271867)

1 December 2017

Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations (English)

1 reference

1 December 2017

R Agah

1

1 reference

PubMed ID

3594487

1 December 2017

H Shau

series ordinal

2

1 reference

PubMed ID

3594487

1 December 2017

A Mazumder

series ordinal

3

1 reference

1 December 2017

1 January 1987

1 reference

Cancer Immunology, Immunotherapy

1 December 2017

1 reference

1 December 2017

24

1 reference

1 December 2017

3

1 reference

1 December 2017

247-252

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00205638

1 December 2017

0 references

cites work

Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.

1 reference

12 December 2020

Regulation of human natural killing by lysosomotropic and thiol-reactive agents.

1 reference

12 December 2020

Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay

1 reference

12 December 2020

Rupture of rat liver lysosomes mediated by L-amino acid esters

1 reference

12 December 2020

Intracellular disruption of rat heart lysosomes by leucine methyl ester: effects on protein degradation

1 reference

12 December 2020

Identification and purification of NK cells with lysosomotropic vital stains: correlation of lysosome content with NK activity

1 reference

12 December 2020

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

12 December 2020

Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization

1 reference

12 December 2020

Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.

1 reference

12 December 2020

The role of the lysosome in natural killing: inhibition by lysosomotropic vital dyes.

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

UPTAKE OF DYES AND DRUGS BY LIVING CELLS IN CULTURE.

1 reference

12 December 2020

Inhibition of human natural killer activity by lysosomotropic agents.

1 reference

12 December 2020

Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor

1 reference

12 December 2020

In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

12 December 2020

Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.

1 reference

12 December 2020

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.

1 reference

12 December 2020

Sr++-induced inhibition of human natural killer (NK) cell-mediated cytotoxicity

1 reference

12 December 2020

Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances

1 reference

12 December 2020

Accumulation of amino acids by lysosomes incubated with amino acid methyl esters

1 reference

12 December 2020

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

12 December 2020

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

12 December 2020

Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205638

1 reference

1 December 2017

1 reference

PubMed ID

3594487